Repertoire Immune Medicines will get $35 million upfront, and possibly $730 million more, in a deal to help Roche’s Genentech ...

Shares of biotech companies involved in the development of monoclonal antibody cancer therapies were moving all over the ...

NS Pharma, a unit of Nippon Shinyaku (OTCPK:NPNKF), said on Monday that the U.S. FDA has granted orphan drug designation to ...

For a limited group of cancer patients who have solid tumors in the stomach, rectum, esophagus and other organs, an ...

The startup, affiliated with China-based antibody designer Helixon Therapeutics, is developing bispecific drugs aimed at ...

AbbVie Inc. raised its profit outlook for the year on better-than-expected sales from newer autoimmune treatments, but warned ...

Seniors with cancer respond just as well as younger patients to immune checkpoint inhibitors immunotherapy treatment.

While some Americans might feel doubtful about prescriptions, others are doing all they can to acquire GLP-1 drugs. Carly ...

Sanofi is handing back a phase 2-stage natural killer (NK) cell engager and canceling another cancer trial as the Big Pharma ...

When the immune system does not function properly, individuals become more susceptible to infections caused by viruses, ...

Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, ...